Cargando…
ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma
BACKGROUND: This study aimed to evaluate the diagnostic value of outer dense fiber 4 (ODF4), melanoma-associated antigen A3 (MAGEA3), and MAGEAB4 mRNAs in transitional cell carcinoma (TCC), using a small amount of cell reverse transcriptase-polymerase chain reaction (RT-PCR) on urinary exfoliated ce...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889501/ https://www.ncbi.nlm.nih.gov/pubmed/28865418 http://dx.doi.org/10.22034/ibj.22.3.160 |
_version_ | 1783312709158174720 |
---|---|
author | Afsharpad, Mandana Nowroozi, Mohammad Reza Ayati, Mohsen Saffari, Mojtaba Nemati, Saeed Mohebbi, Elham Nekoohesh, Leila Zendehdel, Kazem Modarressi, Mohammad Hossein |
author_facet | Afsharpad, Mandana Nowroozi, Mohammad Reza Ayati, Mohsen Saffari, Mojtaba Nemati, Saeed Mohebbi, Elham Nekoohesh, Leila Zendehdel, Kazem Modarressi, Mohammad Hossein |
author_sort | Afsharpad, Mandana |
collection | PubMed |
description | BACKGROUND: This study aimed to evaluate the diagnostic value of outer dense fiber 4 (ODF4), melanoma-associated antigen A3 (MAGEA3), and MAGEAB4 mRNAs in transitional cell carcinoma (TCC), using a small amount of cell reverse transcriptase-polymerase chain reaction (RT-PCR) on urinary exfoliated cells. METHODS: We recruited a total of 105 suspected TCC patients and 54 sex- and age-matched non-TCC controls. The candidates’ genetic expression patterns were investigated with RT-PCR, while reverse transcription quantitative PCR was applied to quantify and compare each mRNA level between cases and control groups. RESULTS: The sensitivity of ODF4, MAGEA3, and MAGEAB4 RT-PCR was 54.8%, 63%, and 53.4%, whereas the specificity was 73.7%, 86%, and 94.7%, respectively. Combining ODF4, MAGEA3, and MAGEAB4 RT-PCR offered a relatively higher sensitivity (83.6%). CONCLUSION: RT-PCR with ODF4, MAGEA3, and MAGEAB4 on urinary exfoliated cells could provide clinicians with a promising method to improve TCC diagnosis, especially in the case of gross hematuria and catheterization. The method used here is non-invasive, simple and convenient, and unlike cytology, it does not rely directly on expert professional opinions. These features can be of particular importance to the management of TCC patients in whom regular and lifelong surveillance is required. |
format | Online Article Text |
id | pubmed-5889501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Pasteur Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-58895012018-05-01 ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma Afsharpad, Mandana Nowroozi, Mohammad Reza Ayati, Mohsen Saffari, Mojtaba Nemati, Saeed Mohebbi, Elham Nekoohesh, Leila Zendehdel, Kazem Modarressi, Mohammad Hossein Iran Biomed J Full Length BACKGROUND: This study aimed to evaluate the diagnostic value of outer dense fiber 4 (ODF4), melanoma-associated antigen A3 (MAGEA3), and MAGEAB4 mRNAs in transitional cell carcinoma (TCC), using a small amount of cell reverse transcriptase-polymerase chain reaction (RT-PCR) on urinary exfoliated cells. METHODS: We recruited a total of 105 suspected TCC patients and 54 sex- and age-matched non-TCC controls. The candidates’ genetic expression patterns were investigated with RT-PCR, while reverse transcription quantitative PCR was applied to quantify and compare each mRNA level between cases and control groups. RESULTS: The sensitivity of ODF4, MAGEA3, and MAGEAB4 RT-PCR was 54.8%, 63%, and 53.4%, whereas the specificity was 73.7%, 86%, and 94.7%, respectively. Combining ODF4, MAGEA3, and MAGEAB4 RT-PCR offered a relatively higher sensitivity (83.6%). CONCLUSION: RT-PCR with ODF4, MAGEA3, and MAGEAB4 on urinary exfoliated cells could provide clinicians with a promising method to improve TCC diagnosis, especially in the case of gross hematuria and catheterization. The method used here is non-invasive, simple and convenient, and unlike cytology, it does not rely directly on expert professional opinions. These features can be of particular importance to the management of TCC patients in whom regular and lifelong surveillance is required. Pasteur Institute 2018-05 /pmc/articles/PMC5889501/ /pubmed/28865418 http://dx.doi.org/10.22034/ibj.22.3.160 Text en Copyright: © Iranian Biomedical Journal http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Full Length Afsharpad, Mandana Nowroozi, Mohammad Reza Ayati, Mohsen Saffari, Mojtaba Nemati, Saeed Mohebbi, Elham Nekoohesh, Leila Zendehdel, Kazem Modarressi, Mohammad Hossein ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma |
title | ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma |
title_full | ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma |
title_fullStr | ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma |
title_full_unstemmed | ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma |
title_short | ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma |
title_sort | odf4, magea3, and mageb4: potential biomarkers in patients with transitional cell carcinoma |
topic | Full Length |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889501/ https://www.ncbi.nlm.nih.gov/pubmed/28865418 http://dx.doi.org/10.22034/ibj.22.3.160 |
work_keys_str_mv | AT afsharpadmandana odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT nowroozimohammadreza odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT ayatimohsen odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT saffarimojtaba odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT nematisaeed odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT mohebbielham odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT nekooheshleila odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT zendehdelkazem odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma AT modarressimohammadhossein odf4magea3andmageb4potentialbiomarkersinpatientswithtransitionalcellcarcinoma |